Silence Therapeutics plc
SLNCF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesSLN
Holders of 5% or more of SLNCF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Silence Therapeutics plc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Silence Therapeutics plc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Silence Therapeutics plc, newest first.
No Schedule 13D or 13G filings on Silence Therapeutics plc are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Silence Therapeutics plc shares.
No Form 144 notices for Silence Therapeutics plc are on file.